Pay in 4 interest-free payments of $6.19 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Manhassett, NY, US
Trial Structure Duration: 48 weeks of treatment Participants: 338 adults randomized 2:1:1:1:1:2:2 to placebo or retatrutide groups Doses tested: 1mg, 4mg, 8mg, 12mg (all with slow titration from 2mg starting dose) Lifestyle intervention: All participants received counseling on diet (500 kcal/day deficit) and exercise (150 min/week) Primary endpoint: Percent weight change at 24 weeks Key secondary endpoints: Weight change at 48 weeks, proportion achieving 5%, 10%, 15% loss The trial used a slow titration protocol to minimize side effects: all groups except the 1mg dose started at 2mg weekly and escalated every 4 weeks
Studies show MT-II reduces food intake in a dose-dependent manner and leads to sustained body mass reduction and lower adiposity, even after appetite normalizes (5)
A product page should be clear about the material being listed and should avoid merging identity language with study interpretation
Cc chuyn gia khuyn co ung glutathione cn tun theo liu lng
Prevention of Muscle Tears: Strengthens tissues and improves their functionality, preventing muscle tears and other injuries
